MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with S

Sapropterin

Sapropterin 100mg soluble tablets sugar free

No stability information

Stability notes for Sapropterin 100mg soluble tablets sugar free

There are no stability notes for this medicine.

Suppliers (6) of Sapropterin 100mg soluble tablets sugar free
Sapropterin 100mg soluble tablets sugar free (Amarox Ltd)
Sapropterin 100mg soluble tablets sugar free (Aspire Pharma Ltd)
Sapropterin 100mg soluble tablets sugar free (Dr Reddy's Laboratories (UK) Ltd)
Sapropterin 100mg soluble tablets sugar free (Logixx Pharma Solutions Ltd)
Sapropterin 100mg soluble tablets sugar free (Teva UK Ltd)
Sapropterin 100mg soluble tablets sugar free (Wockhardt UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.